News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merz North America Announces the End of Court-Ordered Injunction


1/9/2013 9:47:24 AM

GREENSBORO, N.C.--(BUSINESS WIRE)--Merz North America (Merz Aesthetics, Inc. and Merz Pharmaceuticals, LLC) announces that effective today, January 9, 2013, the court-ordered injunction has been lifted and patients and physicians now have access to a broader range of treatment options in aesthetic medicine, dermatology, and neurology. “The violations that led to this injunction were directly attributable to the acts of several individuals, and were entirely incompatible with Merz’s culture. We accepted the injunction as a challenge to us to reinforce compliance training throughout the company and to re-imagine a company-wide compliance program. Last summer we directed all our efforts and resources toward the remediation process, and were pleased when the court agreed to a partial lift of the injunction in November 2012,” said Katrina Church, Vice President - Chief Compliance Officer of Merz, Inc. “We believe that compliance policies are an investment in our company’s future.”

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES